These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1384957)

  • 21. Differentiation and stromal-induced growth promotion of murine prostatic tumors.
    Salm SN; Takao T; Tsujimura A; Coetzee S; Moscatelli D; Wilson EL
    Prostate; 2002 May; 51(3):175-88. PubMed ID: 11967952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME; Deeble PD; Lakhani S; Parsons SJ
    Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial stem cells in human prostate growth and disease.
    Hudson DL
    Prostate Cancer Prostatic Dis; 2004; 7(3):188-94. PubMed ID: 15289813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate basal cells of the prostate: in vitro and in vivo characterization.
    Garraway LA; Lin D; Signoretti S; Waltregny D; Dilks J; Bhattacharya N; Loda M
    Prostate; 2003 May; 55(3):206-18. PubMed ID: 12692787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells in prostate cancer: treating the root of the problem.
    Taylor RA; Toivanen R; Risbridger GP
    Endocr Relat Cancer; 2010 Dec; 17(4):R273-85. PubMed ID: 20660571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.
    Petkova N; Hennenlotter J; Sobiesiak M; Todenhöfer T; Scharpf M; Stenzl A; Bühring HJ; Schwentner C
    Prostate; 2013 Oct; 73(14):1576-90. PubMed ID: 23836489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cells in prostate and prostate cancer development.
    Lam JS; Reiter RE
    Urol Oncol; 2006; 24(2):131-40. PubMed ID: 16520277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cell cultures as models of prostate cancer development.
    Peehl DM
    Endocr Relat Cancer; 2005 Mar; 12(1):19-47. PubMed ID: 15788637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
    Dalrymple S; Antony L; Xu Y; Uzgare AR; Arnold JT; Savaugeot J; Sokoll LJ; De Marzo AM; Isaacs JT
    Cancer Res; 2005 Oct; 65(20):9269-79. PubMed ID: 16230388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistochemistry of the prostate and prostate carcinomas].
    Wernert N
    Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
    Webber MM; Bello D; Quader S
    Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
    Zhou Z; Flesken-Nikitin A; Nikitin AY
    Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratin patterns in prostatic hyperplasia and adenocarcinoma.
    Svanholm H; Nielsen B; Starklint H
    APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle.
    Hayward SW; Baskin LS; Haughney PC; Cunha AR; Foster BA; Dahiya R; Prins GS; Cunha GR
    Acta Anat (Basel); 1996; 155(2):81-93. PubMed ID: 8828706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.
    Untergasser G; Plas E; Pfister G; Heinrich E; Berger P
    Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.